RPGLIFE.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 15:42):

Stats
本日の出来高	3 574.00
平均出来高	19 815.00
時価総額	23.65B
EPS	INR8.01 ( 2024-05-02 )
次の収益日	( INR0 ) 2024-07-25
Last Dividend	INR12.00 ( 2023-07-21 )
Next Dividend	INR0 ( N/A )
P/E	26.97
ATR14	INR1.796 (0.13%)

ボリューム相関

長: -0.02 (neutral)

短: -0.23 (neutral)

Signal:(51.183) Neutral

RPG Life Sciences Limited 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

RPG Life Sciences Limited 相関 - 通貨/商品

0.38
( neutral )

-0.07
( neutral )

0.45
( neutral )

-0.33
( neutral )

-0.08
( neutral )

0.12
( neutral )

RPG Life Sciences Limited 財務諸表

Annual	2023
収益:	INR5.82B
総利益:	INR2.48B (42.66 %)
EPS:	INR53.01

FY	2023
収益:	INR5.82B
総利益:	INR2.48B (42.66 %)
EPS:	INR53.01

FY	2022
収益:	INR5.13B
総利益:	INR3.42B (66.68 %)
EPS:	INR40.90

FY	2022
収益:	INR4.37B
総利益:	INR2.87B (65.64 %)
EPS:	INR31.13

Financial Reports:

No articles found.

RPG Life Sciences Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR9.60 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR12.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

RPG Life Sciences Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.98 - good (79.75%) | Divividend Growth Potential Score: 5.56 - Stable (11.25%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.200	2008-08-11
Last Dividend	INR12.00	2023-07-21
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR51.04	--
Avg. Dividend % Per Year	1.03%	--
Score	3.1	--
Div. Sustainability Score	7.98
Div.Growth Potential Score	5.56
Div. Directional Score	6.77	--

Next Divdend (Est)
(2024-06-27)

INR13.68 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.10

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.40	0.61%
2019	INR2.40	1.01%
2020	INR4.00	1.26%
2021	INR7.20	1.92%
2022	INR9.60	1.57%
2023	INR12.00	1.41%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Knight	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%
HPIL.NS	Dividend Junior	2023-09-29	Annually	5	0.89%
CARERATING.NS	Dividend Knight	2023-07-06	Semi-Annually	12	1.81%
ROSSELLIND.NS	No Dividend Player	2023-07-20	Sporadic	12	0.12%
LFIC.NS	Dividend Junior	2023-08-01	Annually	15	1.73%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.151	1.500	6.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0.171	1.200	4.30	5.16	[0 - 0.3]
returnOnEquityTTM	0.259	1.500	8.23	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.28	0.800	3.62	2.90	[1 - 3]
quickRatioTTM	1.342	0.800	6.81	5.45	[0.8 - 2.5]
cashRatioTTM	0.278	1.500	9.56	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	370.42	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	15.22	2.00	4.93	9.85	[0 - 30]
freeCashFlowPerShareTTM	15.22	2.00	2.39	4.78	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.557	1.000	4.06	4.06	[0.2 - 0.8]
operatingProfitMarginTTM	0.197	1.000	8.05	8.05	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.135	0.800	5.77	4.61	[0.5 - 2]
Total Score				7.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.32	1.000	7.34	0	[1 - 100]
returnOnEquityTTM	0.259	2.50	8.86	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	15.22	2.00	4.93	4.78	[0 - 30]
dividendYielPercentageTTM	0.828	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	15.22	2.00	4.93	9.85	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.952	1.500	6.98	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0432	1.000	-1.419	0	[0.1 - 0.5]
Total Score				5.56

RPG Life Sciences Limited

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.